Resources
-
Automation in Analytical Biopharmaceutical Drug Development with Open-Source Software
Speaker Presentation Golghalyani Vahid, Lonza Biologics, 2020
-
An NMR Based Similarity Metric for Higher Order Structure Assessment among U.S. Marketed Insulin Therapeutics
Speaker Presentation Chen Kang, CDER, FDA, 2020
-
Analytical Testing of Advanced Therapy Medicinal Products: The European Experience So Far
Speaker Presentation Bonamassa Barbara, Italian Medicines Agency (AIFA), 2020
-
Assessment of the Higher Order Structure of Monoclonal Antibody Therapeutics by NMR: Present and Future Directions
Speaker Presentation Aubin Yves, Health Canada, 2020
-
BioAssay Challenges Experienced in the Portuguese OMC
Speaker Presentation Alves de Almeida Maria Fátima, INFARMED I.P., 2020
-
Assessing Refoldability to Select Therapeutic Proteins and Formulations With Lower Aggregation Propensity During Storage
Speaker Presentation Svilenov Hristo, Technical University of Munich, 2021
-
Collision Induced Unfolding: Rapid, Sensitive, and Information-Rich Protein Stability Measurements
Speaker Presentation Ruotolo Brandon, University of Michigan, 2021
-
Five Computational Developability Guidelines for Therapeutic Antibody Profiling
Speaker Presentation Raybould Matthew, University of Oxford, 2021
-
Exploring Protein-Protein Interactions with Fluorescence Correlation Spectroscopy
Speaker Presentation Mueller Joachim, University of Minnesota, 2021
-
Translating Academic Discovery to Patients’ Benefit; Lessons from our 14 Years of SPARK at Stanford and Around the World
Speaker Presentation Mochly-Rosen Daria, Stanford University, 2021
-
Measuring Enzyme Kinetics, Inhibition, and Allostery using Isothermal Titration Calorimetry
Speaker Presentation Mittermaier Anthony, McGill University, 2021
-
A Site of Vulnerability in the Sars-Cov-2 Spike-N-Terminal Domain
Speaker Presentation McCallum Matthew, University of Washington, Seattle, 2021
-
Binding Sites, Orders, Site-Specific Affinities, and Composite Allosteric Behavior Revealed by a Single Mass Spectrometry-Based Approach
Speaker Presentation Liu Roger, Bristol-Myers Squibb, 2021
-
Automated High-throughput Infrared Spectroscopy for Secondary Structure Analysis of Protein Biopharmaceuticals
Speaker Presentation Liu Lucy, Pfizer Inc., 2021
-
Developability Risk Assessment for Dual Variable Domain Immunoglobulin (DVD-Ig™)
Speaker Presentation Filoti Dana, AbbVie Bioresearch Center, Inc., 2021
-
NMR Based Similarity Metrics for Higher Order Structure Assessment Among U.S. Marketed Insulin Drug Products
Speaker Presentation Chen Kang, CDER, FDA, 2021
-
The Unfolded State of Proteins Viewed with Time-resolved FRET, Unnatural Amino Acids and Microfluidic Mixing
Speaker Presentation Bilsel Osman, Microgradient Fluidics LLC, 2021
-
Dynamics of IgG1 Glycoforms and Interaction With FcγR1
Speaker Presentation Anderson Kyle, National Institute of Standards and Technology (NIST), 2021
-
Breakthroughs That Change Patients' Lives -- Development and Optimization of a LabChip® Method for Characterization of a Heavily Sialylated Protein and Its Advantage in High-Throughput InProcess Development Support
Speaker Presentation Yu Qing, Pfizer Inc., 2020
-
A Holistic Strategy to Characterize the In Vivo Stability of Novel Modalities Using Affinity Capture Coupled to LC-MS or CE-Based Methods
Speaker Presentation Wu Cong, Genentech, a Member of the Roche Group, 2020